Market-Moving News for August 10th
BIO-key International, Inc.
AbCellera Biologics, Inc.
Innate Pharma SA
BIO-key International, Inc. BKYI | 0.00 | |
AbCellera Biologics, Inc. ABCL | 0.00 | |
Innate Pharma SA IPHA | 0.00 |
BKYI: -8% | BIO-key And Visualforma Win Contract To Strengthen Digital Identity Security For Portuguese National Security Agency
ABCL: 24% | AbCellera Reports Phase 2 Trial Results Showing Significant Symptom Reduction, Improved Sleep, And Favorable Tolerability For ABCL635
IPHA: 27% | Innate Pharma Partners With Sobi To Advance Lacutamab Toward Phase 3, Targets Accelerated Approval Filing In Sézary Syndrome
